Now, the technology is making headlines again in cancer treatment. For the first time, a personalised mRNA cancer vaccine has ...
For decades, the complexity of the brain, limited understanding of disease biology and the formidable blood-brain barrier ...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, an ...
By adding Parafilm M to its portfolio, Avantor India enables customers to source the product alongside chemicals, reagents, ...
AABB has published a special TRANSFUSION journal supplement examining the growing biotherapies landscape, including cell and ...
The bottleneck is the specialist appointment More than 240 million people aged 65 and over live in the Western Pacific, a ...
For instance, in March 2026, China’s National Medical Products Administration (NMPA) announced approval of the country's ...
The gut-brain axis is moving from an emerging research concept towards a potential platform for precision mental health.
International healthcare leaders should view Taiwan as a top-tier innovator of complete, end-to-end clinical systems” ...
BioSpectrum Asia, October 2026. From symptom control to disease modification: can precision biology, new modalities and blood-brain barrier technologies turn neurology's breakthroughs into a ...
With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their ...
Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPYK04, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results